tirzepatide vision loss The popular #diabetes and weight medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic #retinopathy, a leading cause of loss, according to Dr. Szilárd Kiss and Use of Semaglutide and tirzepatide

To conduct this first pharmacological experiment, effective, high doses of the compounds, validated in preclinical models with metabolic alterations 33,34,35,41,42 , were selected

After one year, people receiving tirzepatide had an average of 27.4 fewer apnea events per hour, compared to an average reduction of 4.8 events per hour for those in the placebo group

While both are effective in helping patients lose weight by influencing gut hormones that control appetite and blood sugar, Mounjaro has demonstrated greater average weight loss in head-to-head clinical trials, with some users losing up to 25 pounds

This action collectively suppresses the production of key pro-inflammatory cytokines (TNF-, IL-6, IL-1) and profibrotic mediators like TGF-1

However, the relevance of this finding to humans is unknown, as the C-cell biology in rodents differs from that in humans

36:30 Do you recommend Ashwagandha for PD